Immix Biopharma Inc. (NASDAQ: IMMX) Stock Information | RedChip

Immix Biopharma Inc. (NASDAQ: IMMX) Listen to this Section


$1.90
+0.0050 ( +0.27% ) 78.2K

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Market Data


Open


$1.90

Previous close


$1.89

Volume


78.2K

Market cap


$52.16M

Day range


$1.83 - $1.92

52 week range


$1.55 - $7.75

Insider Ownership Transactions

Total Amount Purchased: -872,200.00 | $ -1,652,819.00

Date Type Amount Purchased Purchaser
2024-07-31 Buy 3200.00 Hsu Jason
2024-06-21 Sale -33000.00 Marquet Magda
2024-06-21 Sale -33000.00 Chudnovsky Yekaterina
2024-06-21 Sale -33000.00 Hsu Jason
2024-06-21 Sale -33000.00 Ng Carey
2024-06-21 Sale -340000.00 Rachman Ilya M
2024-06-21 Sale -340000.00 Morris Gabriel S
2024-06-21 Sale -33000.00 Adams Helen C.
2024-06-21 Sale -33000.00 BUCHAN JANE
2024-06-10 Buy 2600.00 Rachman Ilya M

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 64 Aug 12, 2024
4 Insider transactions 1 Jul 31, 2024
8-k 8K-related 14 Jul 26, 2024
8-k 8K-related 14 Jul 22, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.